MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression

FEBS Letters

Volumn 588, Issue 18, 2014, Pages 3491-3500

  Li, Jianwei ^a   Tian, Feng ^a   Li, Dajiang ^a   Chen, Jian ^a   Jiang, Peng ^a   Zheng, Shuguo ^a   Li, Xiaowu ^a   Wang, Shuguang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Intrahepatic cholangiocarcinoma; Invasion; miR 605; Proteasome 26S subunit non ATPase 10

Indexed keywords

MICRORNA; MIRN605 MICRORNA, HUMAN; ONCOPROTEIN; PROTEASOME; PSMD10 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BINDING SITE; CANCER TRANSPLANTATION; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; INVASION; METABOLISM; MIR-605; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; PROTEASOME 26S SUBUNIT NON-ATPASE 10; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION; TUMOR VOLUME;

APOPTOSIS; INTRAHEPATIC CHOLANGIOCARCINOMA; INVASION; MIR-605; PROTEASOME 26S SUBUNIT NON-ATPASE 10;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; TUMOR BURDEN;

EID: 84908663746     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.08.008     Document Type: Article

References (30)

1. R.V. Guest, L. Boulter, T.J. Kendall, S.E. Minnis-Lyons, R. Walker, S.J. Wigmore, O.J. Sansom, and S.J. Forbes Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma Cancer Res. 74 2014 1005 1010
2. S. Ariizumi, and M. Yamamoto II. Intrahepatic cholangiocarcinoma Gan to kagaku ryoho Cancer Chemother. 40 2013 1301 1306
3. K.M. Brown, A.D. Parmar, and D.A. Geller Intrahepatic cholangiocarcinoma Surg. Oncol. Clin. N. Am. 23 2014 231 246
4. Z. Bai, Y. Tai, W. Li, C. Zhen, W. Gu, Z. Jian, Q. Wang, J.E. Lin, Q. Zhao, W. Gong, B. Liang, C. Wang, and T. Zhou Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer Cancer Res. 73 2013 4548 4558
5. C. Zhen, L. Chen, Q. Zhao, B. Liang, Y.X. Gu, Z.F. Bai, K. Wang, X. Xu, Q.Y. Han, D.F. Fang, S.X. Wang, T. Zhou, Q. Xia, W.L. Gong, N. Wang, H.Y. Li, B.F. Jin, and J.H. Man Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity Oncogene 32 2013 3452 3460
6. Y. Meng, L. He, X. Guo, S. Tang, X. Zhao, R. Du, J. Jin, Q. Bi, H. Li, Y. Nie, J. Liu, and D. Fan Gankyrin promotes the proliferation of human pancreatic cancer Cancer Lett. 297 2010 9 17
7. H. Higashitsuji, K. Itoh, T. Sakurai, T. Nagao, Y. Sumitomo, T. Masuda, S. Dawson, Y. Shimada, R.J. Mayer, and J. Fujita The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53 Cancer Cell 8 2005 75 87
8. S. Dawson, H. Higashitsuji, A.J. Wilkinson, J. Fujita, and R.J. Mayer Gankyrin: a new oncoprotein and regulator of pRb and p53 Trends Cell Biol. 16 2006 229 233
9. Y.K. Kang, W.H. Kim, H.W. Lee, H.K. Lee, and Y.I. Kim Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma Lab. Invest. J. Tech. Meth. Pathol. 79 1999 477 483
10. A. Eulalio, E. Huntzinger, and E. Izaurralde Getting to the root of miRNA-mediated gene silencing Cell 132 2008 9 14
11. W. Zhou, M.Y. Fong, Y. Min, G. Somlo, L. Liu, M.R. Palomares, Y. Yu, A. Chow, S.T. O'Connor, A.R. Chin, Y. Yen, Y. Wang, E.G. Marcusson, P. Chu, J. Wu, X. Wu, A.X. Li, Z. Li, H. Gao, X. Ren, M.P. Boldin, P.C. Lin, and S.E. Wang Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis Cancer Cell 25 2014 501 515
12. L.M. Kong, C.G. Liao, Y. Zhang, J. Xu, Y. Li, W. Huang, H. Bian, and Z.N. Chen A regulatory loop involving miR-22, Sp1 and c-Myc modulates CD147 expression in breast cancer invasion and metastasis Cancer Res. 2014
13. R.T. Wang, M. Xu, Z.G. Song, C.X. Xu, and H. Jin Decreased Expression of miR-216a contributes to non-small cell lung cancer progression Clinical Cancer Res. off. J. Am. Assoc. Cancer Res. 2014
14. L. Chen, H.X. Yan, W. Yang, L. Hu, L.X. Yu, Q. Liu, L. Li, D.D. Huang, J. Ding, F. Shen, W.P. Zhou, M.C. Wu, and H.Y. Wang The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma J. Hepatol. 50 2009 358 369
15. B. Li, Q. Han, Y. Zhu, Y. Yu, J. Wang, and X. Jiang Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist FEBS J. 279 2012 2393 2398
16. J. Xiao, H. Lin, X. Luo, and Z. Wang MiR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress EMBO J. 30 2011 524 532
17. S. Krzywda, A.M. Brzozowski, H. Higashitsuji, J. Fujita, R. Welchman, S. Dawson, R.J. Mayer, and A.J. Wilkinson The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53 J. Biol. Chem. 279 2004 1541 1545
18. B. Zeng, Z. Li, R. Chen, N. Guo, J. Zhou, Q. Zhou, Q. Lin, D. Cheng, Q. Liao, L. Zheng, and Y. Gong Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3 FEBS Lett. 586 2012 3271 3278
19. M.W. Zhang, M.J. Jin, Y.X. Yu, S.C. Zhang, B. Liu, X. Jiang, Y.F. Pan, Q.I. Li, S.Y. Ma, and K. Chen Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk Mol. Carcinog. 51 Suppl 1 2012 E21 E31
20. H. Mine, T. Sakurai, H. Kashida, S. Matsui, N. Nishida, T. Nagai, S. Hagiwara, T. Watanabe, and M. Kudo Association of gankyrin and stemness factor expression in human colorectal cancer Dig. Dis. Sci. 58 2013 2337 2344
21. Y.H. Kim, J.H. Kim, Y.W. Choi, S.K. Lim, H. Yim, S.Y. Kang, Y.S. Chung, G.Y. Lee, and T.J. Park Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression Exp. Mol. Pathol. 94 2013 360 365
22. Y. Jiang, P. Iakova, J. Jin, E. Sullivan, V. Sharin, I.H. Hong, S. Anakk, A. Mayor, G. Darlington, M. Finegold, D. Moore, and N.A. Timchenko Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer Hepatology 57 2013 1098 1106
23. L. Gao, H. Xie, L. Dong, J. Zou, J. Fu, X. Gao, L. Ou, S. Xiang, and H. Song Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells Mol. Med. Rep. 9 2014 1032 1036
24. W. Qiu, J. Wu, E.M. Walsh, Y. Zhang, C.Y. Chen, J. Fujita, and Z.X. Xiao Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells Oncogene 27 2008 4034 4043
25. V. Ramanathan, G. Jin, C.B. Westphalen, A. Whelan, A. Dubeykovskiy, S. Takaishi, and T.C. Wang P53 gene mutation increases progastrin dependent colonic proliferation and colon cancer formation in mice Cancer Invest. 30 2012 275 286
26. M.R. O'Dell, J.L. Huang, C.L. Whitney-Miller, V. Deshpande, P. Rothberg, V. Grose, R.M. Rossi, A.X. Zhu, H. Land, N. Bardeesy, and A.F. Hezel Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma Cancer Res. 72 2012 1557 1567
27. C.E. Bond, A. Umapathy, I. Ramsnes, S.A. Greco, Z. Zhen Zhao, K.A. Mallitt, R.L. Buttenshaw, G.W. Montgomery, B.A. Leggett, and V.L. Whitehall P53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers Int. J. Cancer J. Int. Cancer 130 2012 1567 1576
28. L. Baker, P.R. Quinlan, N. Patten, A. Ashfield, L.J. Birse-Stewart-Bell, C. McCowan, J.C. Bourdon, C.A. Purdie, L.B. Jordan, J.A. Dewar, L. Wu, and A.M. Thompson P53 mutation, deprivation and poor prognosis in primary breast cancer Br. J. Cancer 102 2010 719 726
29. T. Isa, S. Tomita, A. Nakachi, H. Miyazato, H. Shimoji, T. Kusano, Y. Muto, and M. Furukawa Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma Hepatogastroenterology 49 2002 604 608
30. M. Hsu, M. Sasaki, S. Igarashi, Y. Sato, and Y. Nakanuma KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas Cancer 119 2013 1669 1674